Appropriate chemopreventive strategy for anti-tubercular therapy related liver injury is unsettled: Results from a systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Appropriate chemopreventive strategy for anti-tubercular therapy related liver injury is unsettled: Results from a systematic review and network meta-analysis

Published:2020-10-27 Issue:11 Volume:13 Page:1253-1262
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Singh Anupam Kumar¹^ORCID,Verma Suhang¹^ORCID,Kumar-M Praveen²^ORCID,Soni Hariom²^ORCID,Sharma Samvida³^ORCID,Sharma Swati²^ORCID,Patil Amol²^ORCID,Sharma Vishal¹^ORCID

Affiliation:

1. Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

2. Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

3. Xiamen University, Amoy, China

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2020.1835468

Reference45 articles.

1. Global tuberculosis report 2019. Geneva: World Health Organization, 2019.

2. Guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update. Geneva: World Health Organization, 2017.

3. Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review

4. The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide

5. Extra-abdominal involvement is associated with antitubercular therapy-related hepatitis in patients treated for abdominal tuberculosis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis, prevention and risk-management of drug-induced liver injury due to medications used to treat mycobacterium tuberculosis;Expert Opinion on Drug Safety;2024-09-04

2. Systematic review and network meta-analysis of efficacy and safety of interventions for preventing anti-tuberculosis drug induced liver injury;Scientific Reports;2023-11-14

3. Scopoletin a potential phytochemical therapy for antitubercular treatment drug induced liver injury (ATT-DILI) model in Wistar rats;Journal of Complementary and Integrative Medicine;2023-09-22

4. Biodegradable hydrogel from pectin and carboxymethyl cellulose with Silibinin loading for lung tumor therapy;International Journal of Biological Macromolecules;2023-07

5. Pharmacokinetic Assessment of Isoniazid and Acetylisoniazid in Carbon Tetrachloride-Induced Liver Injury Model in Wistar Rats;Journal of Pharmacy and Bioallied Sciences;2023